Milenia Biotec

Executive Summary

Milenia Biotec is a German diagnostics company founded in 2020 and headquartered in Giessen. The company specializes in the development, manufacture, and sale of universal lateral flow test strips and kits, primarily under the HybriDetect brand. These products enable customers to create their own rapid tests for proteins, antibodies, and nucleic acids. Additionally, Milenia markets finished diagnostic tests such as the QuickLine HIT (heparin-induced thrombocytopenia) and HAMA (human anti-mouse antibody) tests. The company holds ISO 13485:2016 certification, underscoring its commitment to quality management in medical device manufacturing. As a private entity with undisclosed funding, Milenia operates in the competitive point-of-care diagnostics space, leveraging its modular test platform to address diverse applications. While the company has not disclosed financials or major partnerships, its focus on customizable lateral flow technology positions it for growth in the expanding rapid diagnostics market.

Upcoming Catalysts (preview)

• Q4 2026Expansion of HybriDetect product line into new biomarker segments60% success
• Q2 2027Strategic partnership or distribution agreement for QuickLine tests in key markets50% success
• Q1 2027CE marking of a novel point-of-care diagnostic test70% success